D
DexCom, Inc.
DXCM · NASDAQ · USD
Historical Earnings
| Quarter | Reported | EPS est | EPS act | Surprise | Rev est | Rev act | Surprise | Reaction |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | 0.61 | 0.70 | +14.6% | $1.3B | $1.3B | +1.4% | +11.95% |
| Q1 2026 | Apr 30, 2026 | 0.47 | 0.56 | +20.3% | $1.2B | $1.2B | +1.5% | +3.02% |
| Q4 2025 | Feb 12, 2026 | 0.65 | 0.68 | +4.6% | $1.2B | $1.3B | +0.9% | +7.59% |
| Q3 2025 | Oct 30, 2025 | 0.58 | 0.61 | +5.9% | $1.2B | $1.2B | +2.2% | −14.63% |
| Q2 2025 | Jul 30, 2025 | 0.44 | 0.48 | +8.2% | $1.1B | $1.2B | +2.9% | −9.31% |
| Q1 2025 | May 1, 2025 | 0.33 | 0.32 | −2.2% | $1.0B | $1.0B | +1.8% | +16.17% |
| Q4 2024 | Feb 13, 2025 | 0.48 | 0.45 | −6.1% | $1.1B | $1.1B | +0.4% | +5.92% |
| Q3 2024 | Oct 24, 2024 | 0.44 | 0.45 | +2.3% | $990.4M | $994.2M | +0.4% | −1.88% |
Detailed View
Q3 2026Oct 29, 2026Q2 2026Jul 30, 2026+11.95%Q1 2026Apr 30, 2026+3.02%Q4 2025Feb 12, 2026+7.59%Q3 2025Oct 30, 2025−14.63%Q2 2025Jul 30, 2025−9.31%Q1 2025May 1, 2025+16.17%Q4 2024Feb 13, 2025+5.92%Q3 2024Oct 24, 2024−1.88%Q2 2024Jul 25, 2024Q1 2024Apr 25, 2024Q4 2023Feb 8, 2024
2026 Q2 Metrics
| Metric | Estimate | Actual | Surprise | Y/Y |
|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | Beat +1.40% | +13.1% |
| EPS | 0.61 | 0.70 | Beat +14.57% | +45.8% |
| Diluted EPS (GAAP) | — | 0.64 | — | +42.2% |
Documents
- Earnings call transcript — Q2 2026Transcript · Jul 30, 2026 · 59 speaker turns
- 8-K — Q2 20268-K · Sep 10, 2026 · sec.gov
- 10-Q — Q2 202610-Q · Jul 30, 2026 · sec.gov
- 8-K — Q2 20268-K · Jul 30, 2026 · sec.gov